QualityStocksNewsBreaks – GT Biopharma Inc. (GTBP) Announces Public Offering Pricing, Uplists to Nasdaq Capital Market
GT Biopharma (OTCQB: GTBP), an immuno-oncology company focused on innovative therapies based on the company's proprietary TriKE(TM) technology platform, has released the pricing of its recent underwritten public offering of 4,300,000 units. The offering will be priced at $5.50 per unit or prefunded unit, with a unit consisting of one share of the company’s common stock and one warrant to purchase one share of its common stock. The company anticipates gross proceeds from the public offering to reach an estimated $23.6 million customer deductions. In the announcement, the company noted that it has also granted a 45-day over-allotment options to…
